- freely available
The Role of the VEGF-C/VEGFRs Axis in Tumor Progression and Therapy
AbstractVascular endothelial growth factor C (VEGF-C) has been identified as a multifaceted factor participating in the regulation of tumor angiogenesis and lymphangiogenesis. VEGF-C is not only expressed in endothelial cells, but also in tumor cells. VEGF-C signaling is important for progression of various cancer types through both VEGF receptor-2 (VEGFR-2) and VEGF receptor-3 (VEGFR-3). Likewise, both receptors are expressed mainly on endothelial cells, but also expressed in tumor cells. The dimeric VEGF-C undergoes a series of proteolytic cleavage steps that increase the protein binding affinity to VEGFR-3; however, only complete processing, removing both the N- and C-terminal propeptides, yields mature VEGF-C that can bind to VEGFR-2. The processed VEGF-C can bind and activate VEGFR-3 homodimers and VEGFR-2/VEGFR-3 heterodimers to elicit biological responses. High levels of VEGF-C expression and VEGF-C/VEGFRs signaling correlate significantly with poorer prognosis in a variety of malignancies. Therefore, the development of new drugs that selectively target the VEGF-C/VEGFRs axis seems to be an effective means to potentiate anti-tumor therapies in the future.
Share & Cite This Article
Chen, J.-C.; Chang, Y.-W.; Hong, C.-C.; Yu, Y.-H.; Su, J.-L. The Role of the VEGF-C/VEGFRs Axis in Tumor Progression and Therapy. Int. J. Mol. Sci. 2013, 14, 88-107.View more citation formats
Chen J-C, Chang Y-W, Hong C-C, Yu Y-H, Su J-L. The Role of the VEGF-C/VEGFRs Axis in Tumor Progression and Therapy. International Journal of Molecular Sciences. 2013; 14(1):88-107.Chicago/Turabian Style
Chen, Jui-Chieh; Chang, Yi-Wen; Hong, Chih-Chen; Yu, Yang-Hao; Su, Jen-Liang. 2013. "The Role of the VEGF-C/VEGFRs Axis in Tumor Progression and Therapy." Int. J. Mol. Sci. 14, no. 1: 88-107.
Notes: Multiple requests from the same IP address are counted as one view.